DuoGenic StemCells corporation (TPEX:7607)

Market Cap	443.02M +5.5%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	30.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,500
Open	14.55
Previous Close	14.55
Day's Range	14.05 - 14.75
52-Week Range	9.22 - 28.00
Beta	-0.29
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About TPEX:7607

DuoGenic StemCells corporation provides cell therapy products and stem cell culture related services. It also offers cell culture medium, synthesize protein, and stem cell scale up solution; and peripheral blood cell purification cell therapy for Osteoarthritis. The company was founded in 2018 and is based in Taichung, Taiwan.

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2018
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7607